Your browser doesn't support javascript.
loading
Characterization of drug resistance and the defective HIV reservoir in virally suppressed vertically infected children in Mali.
Brice, Josephine; Sylla, Mariam; Desire, Nathalie; Sayon, Sophie; Telly, Fatoumata; Bocar-Fofana, Djeneba; Murphy, Robert; Peytavin, Gilles; Diallo, Souleymane; Nastouli, Eleni; Calvez, Vincent; Marcelin, Anne-Geneviève; Maiga, Almoustapha Issiaka; Lambert-Niclot, Sidonie.
Afiliación
  • Brice J; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Pitié Salpêtrière Hospital, Department of Virology, F-75013 Paris, France.
  • Sylla M; Department of Pediatrics, University Hospital Gabriel Toure, Bamako, Mali.
  • Desire N; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Pitié Salpêtrière Hospital, Department of Virology, F-75013 Paris, France.
  • Sayon S; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Pitié Salpêtrière Hospital, Department of Virology, F-75013 Paris, France.
  • Telly F; Unité d'Epidémiologie Moléculaire de la Résistance du VIH aux ARV, SEREFO, FMOS, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
  • Bocar-Fofana D; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Saint Antoine Hospital, Department of Virology, F-75012 Paris, France.
  • Murphy R; Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, 645 N. Michigan Avenue, Suite 900, Chicago, IL 60611, USA.
  • Peytavin G; AP-HP, Department of Pharmacology, Bichat-Claude Bernard Hospital, F-75018 Paris, France.
  • Diallo S; Unité d'Epidémiologie Moléculaire de la Résistance du VIH aux ARV, SEREFO, FMOS, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
  • Nastouli E; Department of Population, Policy and Practice, University College London GOS Institute of Child Health, London, UK.
  • Calvez V; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Pitié Salpêtrière Hospital, Department of Virology, F-75013 Paris, France.
  • Marcelin AG; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Pitié Salpêtrière Hospital, Department of Virology, F-75013 Paris, France.
  • Maiga AI; Unité d'Epidémiologie Moléculaire de la Résistance du VIH aux ARV, SEREFO, FMOS, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
  • Lambert-Niclot S; Clinical and Microbiology Laboratory, University Hospital Gabriel Toure, Bamako, Mali.
J Antimicrob Chemother ; 75(5): 1272-1279, 2020 05 01.
Article en En | MEDLINE | ID: mdl-32073629
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH Tipo de estudio: Risk_factors_studies Límite: Child / Humans País/Región como asunto: Africa Idioma: En Revista: J Antimicrob Chemother Año: 2020 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH Tipo de estudio: Risk_factors_studies Límite: Child / Humans País/Región como asunto: Africa Idioma: En Revista: J Antimicrob Chemother Año: 2020 Tipo del documento: Article País de afiliación: Francia